[Federal Register Volume 64, Number 123 (Monday, June 28, 1999)]
[Notices]
[Page 34681]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-16261]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Registration

    By Notice dated March 18, 1999, and published in the Federal 
Register on April 1, 1999, (64 FR 15807), Johnson Matthey, Inc., Custom 
Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 
08066, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Difenoxin (9168)...........................  I
Propiram (9649)............................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Methylphenidate (1724).....................  II
Codeine (9050).............................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Meperidine (9230)..........................  II
Methadone (9250)...........................  II
Methadone Intermediate (9254)..............  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Alfentanil (9737)..........................  II
Sufentanil (9740)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances in 
bulk to supply final dosage form manufacturers.
    DEA has considered the factors in Title 21, United States Code, 
Section 823(a) and determined that the registration of Johnson Matthey, 
Inc. to manufacture listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Johnson Matthey, 
Inc. on a regular basis to ensure that the company's continued 
registration is consistent with the public interest. These 
investigations have included inspection and testing of the company's 
physical security systems, audits of the company's records, 
verification of the company's physical security systems, audits of the 
company's records, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the 
Deputy Assistant Administrator, Office of Diversion Control, hereby 
orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed above is granted.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-16261 Filed 6-25-99; 8:45 am]
BILLING CODE 4410-09-M